PCOS 诊断市场：按诊断测试类型、最终用户、地区

2023年，全球PCOS诊断市场规模为35.3亿美元，预计2030年将达到49.6亿美元，2023年至2030年复合年增长率为5%。

图 1. 2023 年 PCOS 诊断的全球市场占有率(%)（按地区）

多囊性卵巢症候群是一种荷尔蒙紊乱，影响十分之一的生产妇女。它会导致月经不规则、受孕困难以及脸部和身体毛髮生长。这种疾病会导致月经不规则、排卵异常、雄性激素水平高、卵巢增大和胰岛素抗性。据估计，全世界有 500 万名育龄妇女受到影响。它还会导致严重的併发症，如不孕症、类风湿性关节炎、高血压、心臟病和糖尿病。

市场动态：

预计 PCOS 病例的快速增加、PCOS 盛行率的增加以及女性对 PCOS 症状认识的提高将推动预测期内全球 PCOS 诊断市场的成长。肥胖、久坐的生活方式和荷尔蒙异常等其他因素也预计将推动市场成长。

然而，PCOS疾病治疗药物严格的监管核准程序和治疗药物的副作用预计将阻碍预测期内全球PCOS诊断市场的成长。

例如，根据世界卫生组织 (WHO) 提供的资料，截至 2023 年 6 月 28 日，多囊性卵巢症候群是一个重要的公共卫生问题，也是影响育龄妇女最常见的荷尔蒙失调之一。据估计，这种疾病影响 8-13% 的育龄妇女，全世界高达 70% 的病例未被确诊。 PCOS 在某些种族群体中的盛行率较高，这些人群往往会出现更多的併发症，尤其是与代谢紊乱相关的併发症。

本研究的主要特点

• 该报告对全球PCOS诊断市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
• 它还阐明了不同细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球 PCOS 诊断市场的主要企业。
• 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
• 全球 PCOS 诊断市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球 PCOS 诊断市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目标
• 假设
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 多囊性卵巢症候群（PCOS）盛行率增加
• 提高认识和早期诊断
• 诊断技术进步
• 医疗费用增加
  • 抑制因素
• 缺乏标准化的诊断标准
• 认识有限且诊断不足
• 成本和承受能力
  • 机会
• 人们对卵巢症候群治疗的认识不断提高
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章 PCOS 诊断市场－冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第 5 章 PCOS 诊断市场，依诊断测试类型，2023-2030 年

• 荷尔蒙测试
• 影像检查
• 验血
• 骨盆腔检查
• 基因检测
• 其他测试

第 6 章 PCOS 诊断市场，按最终用户划分，2023-2030 年

• 医院和诊所
• 不孕不育诊所
• 居家照护环境
• 诊断实验室

第 7 章 PCOS 诊断市场，按地区，2023-2030 年

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第八章竞争形势

• Hoffmann-La Roche Ltd
• Abbott
• Quest Diagnostics
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Bio-Rad Laboratories
• Hologic, Inc.
• Vitrolife
• Myriad Genetics, Inc.
• Ansh Labs
• Diagnostica Stago Inc.
• Beckman Coulter, Inc.
• Randox Laboratories Ltd.
• GE Healthcare
• PrivaPath Diagnostics
• Laboratory Corporation of America Holdings
• SRL Diagnostics

第9章 章节

• 调查方法
• 关于出版商

The global PCOS diagnostic market size was valued at US$ 3.53 Bn in 2023 and is expected to reach US$ 4.96 Bn by 2030, grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

Figure 1. Global PCOS diagnostic Market Share (%), By Region, 2023

PCOS is a hormonal disorder that affects 1 in 10 women of childbearing age. It can cause irregular periods, trouble getting pregnant, and hair growth on the face and body. This condition results in irregular menstrual cycles, abnormal ovulation, high androgen levels, enlarged ovaries, and insulin resistance. It has been found to affect 5 million women of reproductive age globally. It also causes serious complications such as infertility, rheumatoid arthritis, high blood pressure, heart disease, and diabetes.

Market Dynamics:

Surging cases of the PCOS condition, increasing prevalence of PCOS, and increased awareness among women about its symptoms are expected to drive growth of the global PCOS diagnostic market over the forecast period. Other factors, including obesity, a sedentary lifestyle, and hormonal disorders, are also expected to drive the market's growth.

However, stringent regulatory approval processes for PCOS disease drugs and the side effects of treatment drugs are expected to hinder growth of the global PCOS diagnostic market over the forecast period.

For instance, on June 28, 2023, according to data provided by the World Health Organization, PCOS a significant public health problem and is one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age, and up to 70% of cases are undiagnosed worldwide. The prevalence of PCOS is higher among some ethnicities, and these groups often experience more complications, as in particular those related to metabolic problems.

Key features of the study:

• This report provides in-depth analysis of the global PCOS diagnostic market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global PCOS diagnostic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global PCOS diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PCOS diagnostic market

Detailed Segmentation:

• PCOS Diagnostic Market, By Type of Diagnostic Test:
  • Hormone Test
  • Imaging Tests
  • Blood Tests
  • Pelvic Examination
  • Genetic Testing
  • Other Tests
• PCOS Diagnostic Market, By End User:
  • Hospitals and Clinics
  • Fertility Clinics
  • Homecare Settings
  • Diagnostic Laboratories
• PCOS Diagnostic Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Hologic, Inc.
  • Vitrolife
  • Myriad Genetics, Inc.
  • Ansh Labs
  • Diagnostica Stago Inc.
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.
  • GE Healthcare
  • PrivaPath Diagnostics
  • Laboratory Corporation of America Holdings
  • SRL Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market PCOS Diagnostic, By Type of Diagnostic Test
  • Market PCOS Diagnostic, By End User
  • Market PCOS Diagnostic, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Prevalence of PCOS
• Growing Awareness and Early Diagnosis
• Technological Advancements in Diagnostics
• Rising Healthcare Expenditure
  • Restraints
• Lack of Standardized Diagnostic Criteria
• Limited Awareness and under diagnosis
• Cost and Affordability
  • Opportunities
• Growing awareness about polycystic ovarian syndrome treatment
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. PCOS Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. PCOS Diagnostic Market , By Type of Diagnostic Test, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hormone Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Imaging Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Blood Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Pelvic Examination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Other Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. PCOS Diagnostic Market , By End User, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Fertility Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. PCOS Diagnostic Market , By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
• South Africa
• North Africa
• Central Africa

8. Competitive Landscape

• Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vitrolife
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Myriad Genetics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ansh Labs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Diagnostica Stago Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Beckman Coulter, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Randox Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PrivaPath Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Laboratory Corporation of America Holdings
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• SRL Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us